Proton Beam Therapy

Introduction

If your oncologist has mentioned proton beam therapy as part of your treatment plan, you are probably trying to understand how it is different from the radiation therapy most patients receive, and what the experience will be like. Radiation oncology has changed a great deal over the last two decades, and proton beam therapy is one of the more advanced techniques available for selected cancers.

This article explains what proton beam therapy is, how it works, the kinds of tumours doctors commonly treat with it, what planning and treatment look like day by day, the side effects to expect, and how follow-up is organised after the course of treatment ends. It is written for patients (and parents of children with cancer) who already have a diagnosis and are weighing or preparing for proton therapy, rather than for someone trying to choose between radiation and other cancer treatments without specialist input.

Decisions about whether proton beam therapy is the right choice for a particular cancer are made by the patient’s oncology team, taking into account tumour type, location, age, prior treatments, and the available technology. The information here is intended to support that conversation, not replace it.

What Is Proton Beam Therapy?

Proton beam therapy is a form of external beam radiation therapy — meaning the radiation is delivered from a machine outside the body, aimed at a tumour inside it. The difference from conventional radiation is the type of particle used.

Most radiation therapy uses high-energy X-rays, which are also called photons. Photons pass through the body in a straight line, depositing radiation along their entire path — before the tumour, in the tumour, and beyond it. Modern photon techniques (such as IMRT and SBRT, described later) shape this dose carefully, but some radiation always continues past the target.

Proton beam therapy uses protons — positively charged particles taken from hydrogen atoms and accelerated to very high speeds in a large machine called a cyclotron or synchrotron. Protons behave differently from photons inside the body. Each proton travels to a controlled depth, releases most of its energy at that point, and then stops. The point of peak energy release is called the Bragg peak, named after the physicist who first described it.

By adjusting the energy of the proton beam, the radiation oncology team can place this peak precisely where the tumour sits and stop the radiation there. Tissue beyond the tumour receives little or no radiation. Tissue in front of the tumour receives a lower dose than with photon radiation.

Useful Radiation Terms

A few terms appear repeatedly during radiation treatment. Knowing them helps when reading reports or talking to the team.

• Gy (Gray): the unit used to measure absorbed radiation dose. A total course of treatment is usually expressed in Gy.
• Fraction: a single treatment session. The total dose is divided into many fractions to allow healthy tissue to recover between sessions.
• Fractionation: the schedule of dividing the dose — for example, 2 Gy per day, five days a week.
• IMRT (intensity-modulated radiation therapy): an advanced photon technique that shapes the X-ray beam to match the tumour.
• SBRT (stereotactic body radiation therapy): very high-dose photon radiation given in a small number of sessions, used for selected small tumours.
• Pencil beam scanning (PBS): the most precise current form of proton delivery, in which a narrow proton beam is steered through the tumour spot by spot.

How Proton Beam Therapy Works

The clinical aim of any radiation therapy is to damage the DNA inside cancer cells so they cannot divide and grow, while sparing as much healthy tissue as possible. Proton therapy achieves this through the physical behaviour of protons in tissue.

The treatment machine accelerates protons to roughly two-thirds the speed of light. These high-energy protons are then directed by magnets into a treatment room, where a device called a gantry rotates around the patient to deliver the beam from the angle the plan specifies. The proton beam enters the body, travels to the planned depth, releases its energy in the tumour, and stops.

Because the dose drops sharply beyond the tumour, healthy structures behind it receive very little radiation. This is the key clinical advantage doctors look for when choosing proton therapy: when a tumour sits close to an organ that is particularly sensitive to radiation — the spinal cord, the brainstem, the optic nerves, the heart in children — protons can deliver a full tumour dose while keeping dose to that organ low.

Modern centres typically use pencil beam scanning, which moves a narrow proton beam through the tumour volume point by point, painting the dose in three dimensions. This approach allows very tightly shaped dose distributions, even around tumours with complex shapes.

Who Receives Proton Beam Therapy?

Proton beam therapy is not used for every cancer. It is most often considered when reducing radiation dose to nearby healthy tissue is expected to make a meaningful clinical difference — for example, in children, in tumours near critical structures, or when high doses are needed in a small volume.

Cancers for which proton therapy is commonly considered include:

• Paediatric cancers of many types, including medulloblastoma, ependymoma, rhabdomyosarcoma, retinoblastoma, and Hodgkin lymphoma, where reducing long-term radiation effects on a growing body is a major priority
• Brain tumours, including gliomas, meningiomas, and craniopharyngiomas, particularly when located near the brainstem, optic pathways, or cochlea
• Skull base tumours, such as chordomas and chondrosarcomas, which sit next to the brainstem and spinal cord and require very high radiation doses
• Head and neck cancers, including some nasopharyngeal, paranasal sinus, and salivary gland tumours
• Eye (ocular) tumours, particularly uveal melanoma, where proton therapy is well established
• Spinal and paraspinal tumours close to the spinal cord
• Selected lung, oesophageal, liver, and pancreatic cancers, especially when nearby heart, lung, or bowel doses are a concern
• Prostate cancer, in selected situations
• Re-irradiation, when a previously treated area needs more radiation and dose to surrounding tissue must be kept as low as possible
• Lymphomas in young patients, to reduce dose to heart, lungs, and breast tissue

Major professional bodies such as the American Society for Radiation Oncology (ASTRO) and the National Comprehensive Cancer Network (NCCN) describe proton therapy as a generally accepted option for several of these indications, particularly paediatric cancers, skull base tumours, ocular melanoma, and some re-irradiation situations. For other indications — such as some prostate, lung, and breast cancers — the comparative benefit over modern photon techniques is still under study, and the choice depends on the individual case.

Whether proton therapy is appropriate for a specific tumour is decided by the treating oncology team after reviewing imaging, pathology, and the comparison of expected dose distributions with photon plans. In many centres this decision is made by a multidisciplinary tumour board.

Types of Proton Therapy Delivery

Two main delivery techniques are used in modern proton therapy.

Passive Scattering (Uniform Scanning)

In this older technique, a wide proton beam is shaped using physical devices (apertures and compensators) to match the outline and depth of the tumour. It is still used in some centres and works well for certain tumours, but offers less ability to spare healthy tissue near the target.

Pencil Beam Scanning (Intensity-Modulated Proton Therapy)

Pencil beam scanning, sometimes called intensity-modulated proton therapy (IMPT), is the current standard at most newer centres. A narrow proton beam is magnetically steered to deliver dose spot by spot, layer by layer, until the entire tumour volume has received the planned dose. This approach allows much more conformal dose distributions and is particularly useful for irregularly shaped tumours and tumours wrapped around sensitive structures.

Your treating team will choose the delivery technique based on the equipment at the centre and the requirements of your specific tumour.

The Treatment Plan: From Consultation to First Session

Proton beam therapy is delivered as a planned course rather than a single event. The planning process is detailed and usually takes one to two weeks between the consultation and the first treatment session.

Consultation and Decision

The radiation oncologist reviews scans, pathology, and prior treatments. They explain the goals of treatment (cure, local control, symptom relief), the expected schedule, and the side effects to anticipate. If the tumour is one for which both photon and proton plans are reasonable, the team may compare both before deciding.

Simulation

Simulation is the planning appointment where the patient is positioned exactly as they will lie for each treatment. Custom devices may be made to keep the body still and in the same position every day:

• A thermoplastic mask moulded to the face and head for brain, skull base, head, and neck treatments
• A body cradle or vacuum bag shaped to the torso for chest, abdomen, or pelvic treatments
• Bite blocks or mouthpieces for some head and neck plans

Treatment Planning

The radiation oncologist outlines the tumour and the organs to protect on the planning scans. A team of medical physicists and dosimetrists uses specialised software to design a proton plan that delivers the prescribed dose to the tumour while keeping dose to surrounding tissue within strict safety limits. Beam angles, energies, and spot patterns are optimised. The plan is reviewed and approved before treatment begins.

Quality Checks

Before the first session, the plan is verified through measurements on the treatment machine to confirm the dose will be delivered as designed. These checks are repeated regularly throughout the course of treatment.

What Happens During Treatment

A course of proton beam therapy is typically delivered Monday to Friday over four to seven weeks, with weekends as recovery time. Some tumours are treated in fewer sessions using higher doses per fraction (hypofractionation), and a small number of very precisely defined tumours (such as ocular melanomas) are treated in just a few sessions.

For most courses, the total number of sessions is around 20 to 35.

A typical treatment day looks like this:

• You arrive at the centre and change as instructed
• You are positioned on the treatment couch in the immobilisation device made during simulation
• Imaging (low-dose X-rays or cone-beam CT) confirms position before the beam is turned on
• The gantry rotates to the planned angles and delivers the proton dose
• The session ends and you go home or back to the ward

The actual beam-on time is short — usually a few minutes. With set-up, imaging, and verification, the total time in the treatment room is typically 20 to 40 minutes. Radiation cannot be felt, seen, or heard while it is being delivered. After the session, you are not radioactive and you can be around family members, including children and pregnant women, without restriction.

During the course of treatment, the radiation oncology team meets you weekly to review side effects, weight, blood counts where relevant, and any changes in symptoms. Repeat imaging may occasionally be performed during treatment if the tumour or anatomy is changing, and the plan may be adjusted (a process called adaptive replanning).

Side Effects and How They Are Managed

Side effects of proton therapy depend largely on which part of the body is being treated and the total dose given. Because proton therapy reduces dose to tissue beyond the tumour, side effects in those areas are often less severe than with photon radiation. However, the tumour itself and the tissue immediately around it still receive the planned high dose, so local side effects do occur.

General Side Effects

• Fatigue: a gradual tiredness that usually builds over the weeks of treatment and improves over the weeks to months after it ends
• Skin reaction: redness, dryness, itching, or peeling in the treated area, similar to sunburn
• Hair loss in the area where the beam enters or sits
• Mild nausea, depending on the treatment site

Site-Specific Side Effects

Brain and skull base: headache, mild nausea, hair loss in the treated area, fatigue. Children and some adults may experience temporary tiredness that lasts several weeks after treatment.

Head and neck: sore throat, taste changes, dry mouth, mouth ulcers, difficulty swallowing, thick saliva. Nutritional support may be needed during and after treatment.

Chest: mild cough, oesophagitis (inflammation of the food pipe causing pain on swallowing), and skin irritation.

Abdomen: nausea, loose stools, and reduced appetite.

Pelvis (including prostate): increased urinary frequency, mild burning, looser stools, and fatigue.

Eye: redness, dryness, eyelash loss in the treated area, temporary blurring.

Late Effects

Some radiation effects appear months or years after treatment. These depend heavily on the area treated and the dose to nearby organs. They can include:

• Long-term changes in salivary gland function, hearing, or vision when those structures are near the treatment area
• Hormone changes if the pituitary gland is in or near the treatment field
• Effects on growth and development in children, where relevant
• A small long-term risk of a second cancer in or near the treated area, as with all radiation therapy

One of the reasons doctors commonly choose proton therapy for children is to reduce the long-term risk of these late effects by keeping dose to growing tissues and developing organs as low as possible.

Managing Side Effects During Treatment

The radiation oncology team will give specific instructions for the area being treated. General supportive measures often include:

• Drinking enough water through the day
• Eating small, frequent meals with adequate protein
• Using gentle skincare products and avoiding sun exposure on the treated area
• Resting when fatigued and keeping light activity such as walking
• Reporting new or worsening symptoms early rather than waiting

Medications for nausea, pain, mouth care, or skin care may be prescribed as needed.

Response and Follow-Up

Cancers do not usually shrink dramatically during the course of radiation treatment. The damage to cancer cells takes time to translate into a measurable change in tumour size. Imaging to assess response is usually planned several weeks to a few months after the last session.

• A first review a few weeks after treatment ends, to check on acute side effects
• Repeat imaging at intervals defined by the cancer type — often MRI for brain and skull base tumours, CT or PET for other sites
• Clinical examination and discussion of any new symptoms
• Blood tests where relevant
• Long-term surveillance for late effects, including hormonal, neurological, or sensory changes if the treatment area involved those structures

For most cancers, follow-up continues for at least five years and often longer. Paediatric patients are followed throughout childhood and into adulthood for late effects and growth.

Survival and tumour control outcomes after proton therapy depend on cancer type, stage, biology, and combined treatments. Evidence suggests that for selected indications — particularly paediatric tumours, skull base tumours, and ocular melanoma — proton therapy provides excellent tumour control with reduced long-term toxicity. For other cancers, outcomes are similar to those achieved with modern photon techniques, with possible reductions in some side effects. Your oncologist can give you a personalised estimate based on your specific situation.

Combining Proton Therapy with Other Treatments

Proton beam therapy is rarely used alone. It is most often part of a wider plan that may include surgery, chemotherapy, hormonal therapy, immunotherapy, or targeted therapy. The order and combination depend on the cancer.

Surgery and proton therapy: For many tumours, surgery removes as much of the cancer as is safe, and proton therapy treats the area afterwards to reduce the risk of recurrence. In some cases, radiation is given before surgery to shrink the tumour.

Chemotherapy and proton therapy: Some chemotherapy drugs are given alongside radiation to make cancer cells more sensitive to it — an approach called concurrent chemoradiation. This is common in head and neck, oesophageal, lung, and certain brain cancers. Side effects may be more pronounced when the two are combined.

Hormonal and targeted therapies: In cancers such as prostate cancer or some breast and brain tumours, hormonal or targeted drugs may be given before, during, or after radiation.

Immunotherapy: Combinations of immunotherapy and radiation are an active area of research and may be used in some clinical situations.

Paediatric cancer is one of the strongest reasons for considering proton beam therapy. Children’s tissues are still growing, and the long-term effects of radiation on a growing body can be significant. Reducing the dose to healthy tissue around a tumour can lower the risk of:

• Reduced growth in bones and soft tissue
• Hormonal problems if the pituitary or thyroid receives radiation
• Effects on learning, memory, and cognitive development when the brain is treated
• Heart and lung problems from chest radiation
• Second cancers later in life

Major paediatric oncology and radiation oncology bodies generally consider proton therapy a preferred option for many childhood cancers when it is available, particularly central nervous system tumours, sarcomas, and certain lymphomas treated with radiation.

How Treatment Is Adapted for Children

Treating a child with radiation requires particular care:

• Anaesthesia or sedation is often needed for younger children to keep them still during simulation and each treatment session. A paediatric anaesthesia team is involved
• Custom immobilisation is made for small bodies
• Play therapists, child life specialists, and parents help prepare the child and reduce anxiety
• Nutrition and growth are monitored carefully
• Schooling and developmental support are factored into the recovery plan

Long-Term Follow-Up for Children

Children who receive radiation therapy are followed for many years, often into adulthood. Late-effects clinics track growth, hormones, learning, hearing, vision, heart, lung, and dental health, and screen for second cancers in the treated area. Parents will receive a clear schedule of follow-up at the end of treatment.

Daily Life During Treatment

Most adults can continue with light daily activities during a course of proton therapy. Many work part-time or from home, especially in the earlier weeks. Fatigue builds gradually and is often most noticeable in the last two weeks of treatment and the first few weeks afterwards.

Practical suggestions that patients often find helpful:

• Plan treatment appointments at a consistent time of day if possible
• Arrange someone to drive you on days when fatigue is significant
• Keep light exercise such as walking in the daily routine
• Eat regularly, even if appetite drops — small, frequent meals with protein are often easier than large ones
• Sleep more than usual and accept that this is normal during treatment
• Use the centre’s support services — nutrition, counselling, physiotherapy — if offered

Emotional reactions during cancer treatment are common and important. Anxiety, low mood, and sleep problems are well recognised, and most cancer centres provide psycho-oncology support. Speaking up about how you are coping is part of routine care, not a sign of weakness.

Life After Proton Beam Therapy

After the last session, the body continues to respond to radiation for weeks and months. Fatigue and skin reactions usually peak shortly after treatment ends and then steadily improve. Other site-specific side effects gradually settle, though some may take several months. A small number of effects may be long term.

Recovery is supported by:

• Resuming normal activity gradually as energy returns
• Following the centre’s instructions for skin, mouth, or other site-specific care
• Keeping follow-up appointments and imaging on schedule
• Reporting new symptoms — pain, neurological changes, breathing problems, hormonal symptoms — rather than waiting for the next routine review
• Continuing healthy habits: not smoking, limiting alcohol, regular exercise, balanced nutrition

Many patients return to full work and normal life within weeks to a few months of completing a course of proton therapy, depending on the cancer treated and the combined treatments received.

Limitations and Considerations

Proton beam therapy is a powerful tool, but it is not always the best choice. Some honest considerations:

• For many common cancers, modern photon techniques (such as IMRT and SBRT) achieve excellent results with low side effects, and the additional benefit of protons is small or unproven
• Proton centres are fewer than photon centres, which means travel and time away from home can be significant
• Proton dose distributions are more sensitive to changes in anatomy (such as weight loss, tumour shrinkage, or gas in the bowel) than photon plans, and may require re-planning during treatment
• Not all proton centres offer the most advanced delivery techniques (pencil beam scanning), and these differences matter for some tumours

The radiation oncology team will weigh these factors together with the medical benefit when discussing whether proton therapy fits the patient’s situation.

Frequently Asked Questions

Is proton beam therapy painful?

No. Radiation cannot be felt during delivery. Some patients find lying still in the immobilisation device uncomfortable, and side effects in the treated area can cause discomfort, but the treatment itself is painless.

Will I be radioactive after treatment?

No. External beam radiation, including proton therapy, does not make the patient radioactive. You can safely be with family members, including children and pregnant women, immediately after each session.

How long does a course of proton therapy take?

For most cancers, treatment is given daily Monday to Friday for four to seven weeks, with weekends off. Some tumours are treated in fewer sessions; ocular melanoma, for example, is typically treated in only a few sessions.

Is proton therapy better than IMRT or other photon techniques?

The answer depends on the cancer. For paediatric tumours, skull base tumours, ocular melanoma, and some re-irradiation situations, proton therapy is often preferred by major societies because of reduced dose to healthy tissue. For many other cancers, current evidence suggests outcomes similar to modern photon techniques, with possible reductions in some side effects. The choice is a clinical one made by the treating team.

Can proton therapy be repeated?

In some cases, proton therapy is used specifically because it can deliver radiation to a previously treated area while keeping dose to surrounding tissue low. Re-irradiation is a complex decision made by experienced teams.

Will I lose my hair?

Hair loss occurs only in the area the beam enters or sits. Hair on other parts of the body is not affected by radiation. Hair often regrows after treatment, though it may be thinner or a slightly different texture in heavily treated areas.

Can I drive myself to treatment?

Many adults drive themselves, especially early in the course. As fatigue builds in later weeks, it is sensible to arrange transport for some sessions. Patients who receive anaesthesia — mainly children — cannot drive on the day of sedation.

Can I keep working during treatment?

Many patients continue working part-time or from home. Energy levels, the treatment site, and the combined treatments (such as chemotherapy) all affect what is realistic. The radiation oncology team can advise based on the specific situation.

What happens if I miss a session?

Occasional missed sessions are usually made up at the end of the course. Long interruptions can affect outcomes, so the team aims to keep the schedule on track and will discuss any necessary changes.

Is proton therapy used for early-stage cancers only?

No. Proton therapy is used at various stages, including early-stage tumours, locally advanced cancers (often with chemotherapy), and selected metastatic situations where local control is important. The role depends on cancer type and clinical goals.

Conclusion

Proton beam therapy is one of the more precise forms of radiation treatment available today. By placing the peak of the radiation dose at a controlled depth and stopping it there, the technique can reduce radiation to healthy tissue around a tumour. For selected cancers — particularly in children, near critical structures, and in re-irradiation — this can translate into meaningful clinical benefit, both in tumour control and in reducing long-term side effects.

For other cancers, the choice between proton and modern photon radiation is a careful clinical decision based on individual tumour characteristics, available technology, and the patient’s overall plan. The radiation oncology team, working with the wider tumour board, is best placed to weigh those factors.

Understanding what proton therapy is, how planning and treatment unfold, what side effects to expect, and how follow-up is organised can make the course of treatment less daunting and the conversations with the medical team more productive.